Your session is about to expire
← Back to Search
Telemedicine Supportive Care for Cancer Patients
N/A
Waitlist Available
Led By Judith Nelson, MD,JD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
planned for Supportive Care Service follow-up visits, but none yet completed
completed an initial in-person clinic visit (i.e. an IR/NV or AFX visit) at Rockefeller Outpatient Pavilion with Dr. Saldivar, Dr. Martin, Supportive Care physicians, or Andrea Dolan, a Supportive Care nurse practitioner
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 14
Awards & highlights
Study Summary
This trial will test whether "virtual" medical visits using telecommunications technologies are as effective as in-person visits for cancer patients receiving supportive care.
Who is the study for?
This trial is for adults over 18 with any type of solid tumor who've had an initial in-person visit at Rockefeller Outpatient Pavilion and are set up for follow-up visits. They must be enrolled on the MyMSK portal and live in New York, New Jersey, or Connecticut. Non-English speakers needing an interpreter can't join.Check my eligibility
What is being tested?
The study compares two types of follow-up care for cancer patients: traditional in-person clinic visits versus telemedicine visits conducted from home using online communication tools to see if they're equally effective.See study design
What are the potential side effects?
Since this trial involves supportive care services rather than medication, there aren't typical drug side effects. However, technical issues or a lack of personal interaction may affect patient satisfaction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for follow-up visits with Supportive Care Services but haven't had any yet.
Select...
I have had an in-person visit at Rockefeller Outpatient Pavilion with specified healthcare providers.
Select...
I am 18 years old or older.
Select...
I have a solid tumor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 14
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 14
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Health-Related Quality of Life: FACT-G
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Home Telemedicine follow-upExperimental Treatment1 Intervention
Group II: In-person follow-upActive Control1 Intervention
Due to the COVID-19 pandemic, patients originally randomized to the in-person group received telemedicine visits. Thus, the researchers will expand our sample for these interviews to include patients who have completed at least 2 telemedicine follow-up visits whether they were originally randomized to the in-person group or the home telemedicine group.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,928 Previous Clinical Trials
591,775 Total Patients Enrolled
Judith Nelson, MD,JDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need an interpreter to communicate with doctors or to understand medical forms.I am scheduled for follow-up visits with Supportive Care Services but haven't had any yet.I have had an in-person visit at Rockefeller Outpatient Pavilion with specified healthcare providers.I am 18 years old or older.I have a solid tumor.
Research Study Groups:
This trial has the following groups:- Group 1: Home Telemedicine follow-up
- Group 2: In-person follow-up
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research effort currently enrolling participants?
"As evidenced on clinicaltrials.gov, this medical trial is not presently accepting participants; the initial posting having been made October 24th 2019 and last updated July 19th 2022. Despite this, 493 other trials are actively recruiting patients across various locations at present."
Answered by AI
Share this study with friends
Copy Link
Messenger